To explore the downstream regulatory target gene of miR-361-3p, we adopted TargetScan prediction and found that miR-361-3p had a binding site with BTG2 in the pancreatic cancer cells (Figure 6A). Here, BTG2 is linked to familial pancreatic carcinoma.